↓ Skip to main content

Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

Overview of attention for article published in BMC Musculoskeletal Disorders, October 2013
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter
5 tweeters

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
116 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
Published in
BMC Musculoskeletal Disorders, October 2013
DOI 10.1186/1471-2474-14-298
Pubmed ID
Authors

Ying He, Angel YS Wong, Esther W Chan, Wallis CY Lau, Kenneth KC Man, Celine SL Chui, Alan J Worsley, Ian CK Wong

Abstract

Tofacitinib is a disease-modifying antirheumatic drug (DMARD) which was recently approved by US Food and Drug Administration (FDA). There are several randomised clinical trials (RCTs) that have investigated the efficacy and safety of tofacitinib in adult patients with rheumatoid arthritis (RA). A systematic review with a meta-analysis of RCTs was undertaken to determine the efficacy and safety of tofacitinib in treating patients with RA.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Brazil 1 <1%
Unknown 113 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 16%
Researcher 18 16%
Other 16 14%
Student > Bachelor 14 12%
Student > Ph. D. Student 11 9%
Other 20 17%
Unknown 18 16%
Readers by discipline Count As %
Medicine and Dentistry 46 40%
Pharmacology, Toxicology and Pharmaceutical Science 13 11%
Agricultural and Biological Sciences 12 10%
Chemistry 4 3%
Biochemistry, Genetics and Molecular Biology 3 3%
Other 16 14%
Unknown 22 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2013.
All research outputs
#5,136,725
of 10,479,368 outputs
Outputs from BMC Musculoskeletal Disorders
#979
of 2,302 outputs
Outputs of similar age
#56,194
of 151,765 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#30
of 80 outputs
Altmetric has tracked 10,479,368 research outputs across all sources so far. This one has received more attention than most of these and is in the 50th percentile.
So far Altmetric has tracked 2,302 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 151,765 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.